ARCHIVES

Interim Analysis of Phase III Data Preferable For Accelerated Approval, FDA’s Pazdur Says

This article is from The Cancer Letter archive.

Vol. 28 No. 32 | September 6, 2002

Download PDF Visit The Full Archive

Related Articles

LAK –IL-2 Studies Continue, Moertel Editorial Blasted

March 13, 1987

In Brief: Curt Appointment Now Official; Bipartisan Effort Seeks $150 Million FDA Budget Increase

April 21, 1989

NIH To Give 3 Percent Increase to Grants

March 20, 2009

NIH oncology peer reviewers are protesting the outcome of a recent meeting in which their own grant applications fared so poorly that the reviewers said they were penalized for their service.

May 6, 2005

FDA Approves Lymphoseek For Imaging Lymph Nodes

March 29, 2013

Also: Court Will Reconsider Ruling on Access To Experimental Drugs.

December 1, 2006